| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |